AbbVie Hopes Imbruvica, Marivet Build Momentum Before Humira Downturn

With AbbVie's next-generation HCV combo Marivet, newly approved in Europe, the company can look to it and growing sales from Imbruvica to help make up for Humira revenue losses that may start in 2018.